• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
GSTP1 rs4147581 C>G and NLRP3 rs3806265 T>C as Risk Factors for Chronic Obstructive Pulmonary Disease: A Case-Control Study.GSTP1 rs4147581 C>G 和 NLRP3 rs3806265 T>C 是慢性阻塞性肺疾病的危险因素:一项病例对照研究。
Int J Chron Obstruct Pulmon Dis. 2024 Feb 22;19:489-500. doi: 10.2147/COPD.S445680. eCollection 2024.
2
Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者自我管理干预措施(包括针对病情加重的行动计划)与常规护理的比较。
Cochrane Database Syst Rev. 2017 Aug 4;8(8):CD011682. doi: 10.1002/14651858.CD011682.pub2.
3
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.
4
Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.噻托溴铵与长效β受体激动剂治疗稳定期慢性阻塞性肺疾病的比较
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009157. doi: 10.1002/14651858.CD009157.pub2.
5
Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD).干预措施以提高慢性阻塞性肺疾病(COPD)药物治疗的依从性。
Cochrane Database Syst Rev. 2021 Sep 8;9(9):CD013381. doi: 10.1002/14651858.CD013381.pub2.
6
Self-management interventions for people with chronic obstructive pulmonary disease.针对慢性阻塞性肺疾病患者的自我管理干预措施。
Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD002990. doi: 10.1002/14651858.CD002990.pub4.
7
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.免疫刺激剂与安慰剂在预防慢性支气管炎或慢性阻塞性肺疾病成人恶化中的比较。
Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2.
8
Tiotropium versus placebo for chronic obstructive pulmonary disease.噻托溴铵与安慰剂治疗慢性阻塞性肺疾病的比较
Cochrane Database Syst Rev. 2012 Jul 11(7):CD009285. doi: 10.1002/14651858.CD009285.pub2.
9
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.
10
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.评估慢性阻塞性肺疾病干预措施的比较效果:面向临床医生的网状Meta分析教程
Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x.

本文引用的文献

1
GST polymorphism as a predictive biomarker for modulating the susceptibility to chronic obstructive pulmonary disease: A North Indian study.GST 多态性作为预测生物标志物,调节对慢性阻塞性肺疾病易感性:一项北印度研究。
Exp Physiol. 2024 Feb;109(2):302-311. doi: 10.1113/EP091339. Epub 2023 Nov 10.
2
The Study of the Influence of Variants on Chronic Obstructive Pulmonary Disease.变异对慢性阻塞性肺疾病影响的研究
COPD. 2023 Dec;20(1):338-347. doi: 10.1080/15412555.2023.2270729. Epub 2023 Oct 31.
3
and polymorphisms are associated with COPD risk: a systematic review and meta-analysis.并且多态性与慢性阻塞性肺疾病风险相关:一项系统评价和荟萃分析。
Front Genet. 2023 May 22;14:1128985. doi: 10.3389/fgene.2023.1128985. eCollection 2023.
4
Association between and Variants and Susceptibility to Chronic Kidney Disease.与 和 变异体与慢性肾脏病易感性的关联。
Int J Mol Sci. 2023 Feb 20;24(4):4184. doi: 10.3390/ijms24044184.
5
Genetic polymorphisms and their effects on the severity of silicosis in workers exposed to silica in Brazil.遗传多态性及其对巴西二氧化硅暴露工人矽肺严重程度的影响。
J Bras Pneumol. 2022 Nov 4;48(5):e20220167. doi: 10.36416/1806-3756/e20220167. eCollection 2022.
6
Chronic Obstructive Pulmonary Disease Definition: Is It Time to Incorporate the Concept of Failure of Lung Regeneration?慢性阻塞性肺疾病的定义:是时候纳入肺再生失败的概念了吗?
Am J Respir Crit Care Med. 2023 Feb 1;207(3):366-367. doi: 10.1164/rccm.202208-1508LE.
7
Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision.慢性阻塞性肺疾病的定义与命名:是时候修订了。
Am J Respir Crit Care Med. 2022 Dec 1;206(11):1317-1325. doi: 10.1164/rccm.202204-0671PP.
8
Pathological Mechanism and Targeted Drugs of COPD.COPD 的病理机制与靶向药物。
Int J Chron Obstruct Pulmon Dis. 2022 Jul 12;17:1565-1575. doi: 10.2147/COPD.S366126. eCollection 2022.
9
A novel circRNA-SNP may increase susceptibility to silicosis.一种新型环状 RNA 单核苷酸多态性可能增加矽肺易感性。
Ecotoxicol Environ Saf. 2022 Sep 1;242:113855. doi: 10.1016/j.ecoenv.2022.113855. Epub 2022 Jul 11.
10
lncRNA GAS5 promotes pyroptosis in COPD by functioning as a ceRNA to regulate the miR‑223‑3p/NLRP3 axis.长链非编码 RNA GAS5 通过作为 ceRNA 调节 miR-223-3p/NLRP3 轴促进 COPD 中的细胞焦亡。
Mol Med Rep. 2022 Jul;26(1). doi: 10.3892/mmr.2022.12735. Epub 2022 May 18.

GSTP1 rs4147581 C>G 和 NLRP3 rs3806265 T>C 是慢性阻塞性肺疾病的危险因素:一项病例对照研究。

GSTP1 rs4147581 C>G and NLRP3 rs3806265 T>C as Risk Factors for Chronic Obstructive Pulmonary Disease: A Case-Control Study.

机构信息

Institute of Public Health, Gansu University of Chinese Medicine, Lanzhou, Gansu, People's Republic of China.

Department of Respiratory Medicine, Affiliated Hospital of Gansu University of Chinese Medicine, Lanzhou, Gansu, People's Republic of China.

出版信息

Int J Chron Obstruct Pulmon Dis. 2024 Feb 22;19:489-500. doi: 10.2147/COPD.S445680. eCollection 2024.

DOI:10.2147/COPD.S445680
PMID:38410140
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10896110/
Abstract

BACKGROUND

Chronic obstructive pulmonary disease (COPD) is a chronic respiratory ailment influenced by a blend of genetic and environmental factors. Inflammatory response and an imbalance in oxidative-antioxidant mechanisms constitute the primary pathogenesis of COPD. Glutathione S-transferase P1(GSTP1) plays a pivotal role as an antioxidant enzyme in regulating oxidative-antioxidant responses in the pulmonary system. The activation of the NOD-like receptor thermal protein domain (NLRP3) inflammatory vesicle can trigger an inflammatory response. Several investigations have implicated GSTP1 and NLRP3 in the progression of COPD; nonetheless, there remains debate regarding this mechanism.

METHODS

Employing a case-control study design, 312 individuals diagnosed with COPD and 314 healthy controls were recruited from Gansu Province to evaluate the correlation between GSTP1 (rs4147581C>G and rs1695A>G) and NLRP3 (rs3806265T>C and rs10754558G>C) polymorphisms and the susceptibility to COPD.

RESULTS

The presence of the GSTP1 rs4147581G allele substantially elevated the susceptibility to COPD (CGvs.CC:OR=3.11,95% CI=1.961-4.935, <0.001;GGvs.CC:OR=2.065,95% CI=1.273-3.350, =0.003; CG+GGvs.CC:OR=2.594,95% CI=1.718-3.916, <0.001). Similarly, the NLRP3rs3806265T allele significantly increased the susceptibility to COPD (TC:TT:OR=0.432,95% CI=0.296-0.630; TC+CCvs.TT:OR=2.132,95% CI=1.479-3.074, <0.001). However, no statistically significant association was discerned between the rs1695A>G and rs10754558G>C polymorphisms and COPD susceptibility (>0.05).

CONCLUSION

In summary, this study ascertained that the GSTP1 rs4147581C>G polymorphism is associated with increased COPD susceptibility, with the G allele elevating the risk of COPD. Similarly, the NLRP3 rs3806265T>C polymorphism is linked to elevated COPD susceptibility, with the T allele heightening the risk of COPD.

摘要

背景

慢性阻塞性肺疾病(COPD)是一种受遗传和环境因素综合影响的慢性呼吸道疾病。炎症反应和氧化-抗氧化机制失衡是 COPD 的主要发病机制。谷胱甘肽 S-转移酶 P1(GSTP1)作为一种抗氧化酶,在调节肺部的氧化-抗氧化反应中发挥着关键作用。NOD 样受体热蛋白结构域(NLRP3)炎性囊泡的激活可以引发炎症反应。多项研究表明 GSTP1 和 NLRP3 参与了 COPD 的进展;然而,关于这种机制仍存在争议。

方法

采用病例对照研究设计,从甘肃省招募了 312 名 COPD 患者和 314 名健康对照者,评估 GSTP1(rs4147581C>G 和 rs1695A>G)和 NLRP3(rs3806265T>C 和 rs10754558G>C)多态性与 COPD 易感性的相关性。

结果

GSTP1 rs4147581G 等位基因的存在显著增加了 COPD 的易感性(CG 对 CC:OR=3.11,95%CI=1.961-4.935,<0.001;GG 对 CC:OR=2.065,95%CI=1.273-3.350,=0.003;CG+GG 对 CC:OR=2.594,95%CI=1.718-3.916,<0.001)。同样,NLRP3 rs3806265T 等位基因显著增加了 COPD 的易感性(TC:TT:OR=0.432,95%CI=0.296-0.630;TC+CC 对 TT:OR=2.132,95%CI=1.479-3.074,<0.001)。然而,rs1695A>G 和 rs10754558G>C 多态性与 COPD 易感性之间没有发现统计学上的显著关联(>0.05)。

结论

综上所述,本研究证实 GSTP1 rs4147581C>G 多态性与 COPD 易感性增加有关,G 等位基因增加了 COPD 的发病风险。同样,NLRP3 rs3806265T>C 多态性与 COPD 易感性增加有关,T 等位基因增加了 COPD 的发病风险。